계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Azellon Cell Therapeutics
company
About
Azellon Cell Therapeutics is focused on developing stem cell therapy for the repair of avascular meniscal tears.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- £1.60M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Azellon is focused on developing stem cell therapy for the repair of avascular meniscal tears. Today orthopaedic surgeons are partially or fully removing the meniscus which over 4-6 years will lead to osteoarthritic changes in the knee joint. The technology behind Azellon was developed by Professor Anthony Hollander over the last 5 years and has already been proven highly successful in an in-vitro model.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£1.60M
Azellon Cell Therapeutics has raised a total of
£1.60M
in funding over 2 rounds. Their latest funding was raised on
Apr 20, 2009 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2009 | Seed | £1.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Azellon Cell Therapeutics is funded by 1 investors.
Wyvern Seed Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Wyvern Seed Fund
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
